Do you have a strategy for responding to the temperamental IPO market and making the most of alternative financing strategies?
Foley & Lardner LLP and the NanoBusiness Alliance are pleased to invite senior business executives and investors to participate in a roundtable discussion addressing how nanotechnology companies can develop financing strategies for success.
Discussion topics include:
- Financing growth and development of a nanotechnology company with long product development timelines, little or no near-term revenue, and potential applications in many industries
- Determining when the sale of your company is the most viable and what factors have made other nanotechnology companies attractive targets
- Deciding whether to go IPO, OTC, AIM, or private equity
- Exploring nontraditional financing options
- Positioning your company for the best financing options
Confirmed Boston Attendees:
Tim Cesarek, President, Koch Genesis Company, LLC
Mark Modzelewski, Vice President, NanoDynamics
Justin Hall-Tipping, Senior Managing Partner, NanoHoldings LLC
Scott Livingston, Managing Director, The Livingston Group, Axiom Capital Management Inc.
Curt Creely, Partner, Foley & Lardner LLP
People
Related Insights
June 3, 2025
Health Care Law Today
Risk Bearing Entity Requirements: Massachusetts
This blog discusses the regulatory requirements that apply to risk-bearing entities in Massachusetts, including recent updates introduced by Chapter 343 of the Massachusetts Acts of 2024.
June 2, 2025
Labor & Employment Law Perspectives
Update on DHS Efforts to Terminate TPS and Parole Status for Various Immigrant Groups
The U.S. Department of Homeland Security (DHS) has been actively working to terminate Temporary Protected Status (TPS) and Parole status…
June 2, 2025
Labor & Employment Law Perspectives
Circuit Split Deepens on “Harm” as a Failure to Accommodate Element
The split among federal circuit courts of appeal as to whether a disabled worker must show harm in bringing a failure to accommodate…